Immunic, Inc.IMUXNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
35.00%
↑ 538% above average
Average (39q)
-8.00%
Historical baseline
Range
High:86.44%
Low:-381.12%
CAGR
+0.2%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 35.00% |
| Q2 2025 | 20.00% |
| Q1 2025 | 10.71% |
| Q4 2024 | -16.67% |
| Q3 2024 | -14.29% |
| Q2 2024 | 30.00% |
| Q1 2024 | 37.50% |
| Q4 2023 | 5.88% |
| Q3 2023 | 5.56% |
| Q2 2023 | -1.89% |
| Q1 2023 | 80.94% |
| Q4 2022 | -280.82% |
| Q3 2022 | -1.39% |
| Q2 2022 | 0.00% |
| Q1 2022 | 14.29% |
| Q4 2021 | -10.53% |
| Q3 2021 | 7.32% |
| Q2 2021 | 49.69% |
| Q1 2021 | -201.85% |
| Q4 2020 | 22.86% |
| Q3 2020 | 22.22% |
| Q2 2020 | -13.92% |
| Q1 2020 | -5.33% |
| Q4 2019 | 8.54% |
| Q3 2019 | 46.05% |
| Q2 2019 | 86.44% |
| Q1 2019 | -381.12% |
| Q4 2018 | 79.33% |
| Q3 2018 | 5.85% |
| Q2 2018 | 11.86% |
| Q1 2018 | 1.59% |
| Q4 2017 | -16.65% |
| Q3 2017 | -0.60% |
| Q2 2017 | 23.83% |
| Q1 2017 | -5.54% |
| Q4 2016 | -13.76% |
| Q3 2016 | -6.11% |
| Q2 2016 | 3.43% |
| Q1 2016 | 9.06% |
| Q4 2015 | 32.62% |